Alaunos Therapeutics Stock Pattern Recognition Rising and Falling Three Methods

TCRT Stock

USD 3.37 0.18 5.64%

Use the pattern recognition workspace to apply Rising and Falling Three Methods recognition and other studies to Alaunos Therapeutics. The focus on pattern recognition signals tied to momentum and continuation helps organize trend, volatility, and risk context for Alaunos Therapeutics.

Symbol

Recognition

The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was fourteen with a total number of output elements of forty-seven. The function did not return any valid pattern recognition events for the selected time horizon. The Rising/Falling Three Methods may indicate that Alaunos Therapeutics has been in a downtrend and is about to experience bullish continuation signal

Alaunos Therapeutics Technical Analysis Modules

Most technical analysis of Alaunos Therapeutics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Alaunos from various momentum indicators to cycle indicators. When you analyze Alaunos charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

	Cycle Indicators
	Math Operators
	Math Transform
	Momentum Indicators
	Overlap Studies
	Pattern Recognition
	Price Transform
	Statistic Functions
	Volatility Indicators
	Volume Indicators

Stock Overview, Methodology & Data Sources

Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. Alaunos Therapeutics, Inc. is headquartered in Houston, Texas. Alaunos Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 41 people. As a micro-cap equity, Alaunos Therapeutics is reviewed for growth durability, margin stability, and risk discipline. Current metrics include P/B of 2.76. Alaunos Therapeutics has a market cap of 7.12 M, ROE of -145.65%.

Methodology

Unless otherwise specified, financial data for Alaunos Therapeutics is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Alaunos (USA Stocks:TCRT) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: The dataset for Alaunos Therapeutics incorporates public filings and market reference sources and official institutional disclosures, including U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Patent & Trademark Office (USPTO). Some inputs may not update instantaneously. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.

Analyst Sources

Alaunos Therapeutics may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.

This content is curated and reviewed by:

Gabriel Shpitalnik - Member of Macroaxis Editorial Board

Learn to be your own money manager

Tracking Alaunos Therapeutics inside a portfolio is useful because individual winners can still weaken diversification or distort overall risk targets. A disciplined tracking process turns performance data into better decisions instead of more noise.

Did you try this?

Run Balance Of Power Now

Balance Of Power

Check stock momentum by analyzing Balance Of Power indicator and other technical ratios

All Next

Launch Module

Alaunos Therapeutics pair trading

Pair trading with Alaunos Therapeutics can help investors hedge some company-specific exposure by balancing a long view with an offsetting position. The key question is whether the second leg adds real hedge value instead of just creating a more complex version of the same risk.

Alaunos Therapeutics Pair Trading

Alaunos Therapeutics Pair Trading Analysis

Identifying correlated replacements for Alaunos Therapeutics is particularly important in concentrated portfolios where Alaunos Therapeutics represents a large allocation. A poor substitute could introduce unintended factor or sector risks that persist beyond the required waiting period.

Correlation is not causation, but for Alaunos Therapeutics it is a practical tool. High correlations between Alaunos Therapeutics and a potential addition to the portfolio flag concentrated exposure, while low correlations signal diversification potential.

Correlation analysis and pair evaluation for Alaunos Therapeutics can support hedging context. The method can be applied across sectors and broader equity sets.

Pair Correlation Correlation Matching

Additional Tools for Alaunos Stock Analysis

	Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
	Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities
	Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital
	Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
	Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
	ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
	Portfolio Anywhere Track or share privately all of your investments from the convenience of any device
	Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios
	Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC